Raymond James & Associates’s Aramark ARMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.77M | Buy |
97,328
+80,300
| +472% | +$2.83M | ﹤0.01% | 1850 |
|
|
2024
Q2 | $579K | Buy |
17,028
+735
| +5% | +$23.9K | ﹤0.01% | 2976 |
|
|
2024
Q1 | $530K | Buy |
16,293
+2,469
| +18% | +$74.4K | ﹤0.01% | 3030 |
|
|
2023
Q4 | $388K | Sell |
13,824
-11,242
| -45% | -$305K | ﹤0.01% | 3115 |
|
|
2023
Q3 | $628K | Buy |
25,066
+6,655
| +36% | +$187K | ﹤0.01% | 2745 |
|
|
2023
Q2 | $572K | Buy |
18,411
+856
| +5% | +$23.3K | ﹤0.01% | 2848 |
|
|
2023
Q1 | $454K | Sell |
17,555
-14,499
| -45% | -$413K | ﹤0.01% | 2980 |
|
|
2022
Q4 | $957K | Buy |
32,054
+16,099
| +101% | +$444K | ﹤0.01% | 2453 |
|
|
2022
Q3 | $359K | Sell |
15,955
-384,951
| -96% | -$9.58M | ﹤0.01% | 3068 |
|
|
2022
Q2 | $8.87M | Sell |
400,906
-24,056
| -6% | -$594K | 0.01% | 1044 |
|
|
2022
Q1 | $11.5M | Sell |
424,962
-1,966
| -0.5% | -$51.3K | 0.01% | 988 |
|
|
2021
Q4 | $11.4M | Sell |
426,928
-18,876
| -4% | -$494K | 0.01% | 1025 |
|
|
2021
Q3 | $10.6M | Sell |
445,804
-8,419
| -2% | -$208K | 0.01% | 1023 |
|
|
2021
Q2 | $12.2M | Sell |
454,223
-1,553
| -0.3% | -$42.6K | 0.01% | 968 |
|
|
2021
Q1 | $12.4M | Sell |
455,776
-29,306
| -6% | -$803K | 0.01% | 905 |
|
|
2020
Q4 | $13.5M | Sell |
485,082
-45,365
| -9% | -$1.09M | 0.01% | 799 |
|
|
2020
Q3 | $10.1M | Sell |
530,447
-17,248
| -3% | -$307K | 0.01% | 851 |
|
|
2020
Q2 | $8.93M | Sell |
547,695
-8,687
| -2% | -$152K | 0.01% | 877 |
|
|
2020
Q1 | $8.02M | Buy |
556,382
+219,078
| +65% | +$5.77M | 0.01% | 833 |
|
|
2019
Q4 | $10.6M | Buy |
337,304
+5,968
| +2% | +$187K | 0.01% | 875 |
|
|
2019
Q3 | $10.4M | Sell |
331,336
-67,519
| -17% | -$1.9M | 0.01% | 846 |
|
|
2019
Q2 | $10.4M | Buy |
398,855
+131,024
| +49% | +$3.07M | 0.02% | 837 |
|
|
2019
Q1 | $5.71M | Buy |
267,831
+194,405
| +265% | +$4.35M | 0.01% | 1115 |
|
|
2018
Q4 | $1.54M | Buy |
73,426
+3,490
| +5% | +$90.6K | ﹤0.01% | 1817 |
|
|
2018
Q3 | $2.17M | Buy |
69,936
+167
| +0.2% | +$4.88K | ﹤0.01% | 1760 |
|
|
2018
Q2 | $1.87M | Sell |
69,769
-484
| -0.7% | -$13.4K | ﹤0.01% | 1788 |
|
|
2018
Q1 | $2.01M | Buy |
70,253
+2,287
| +3% | +$70.1K | ﹤0.01% | 1700 |
|
|
2017
Q4 | $2.1M | Buy |
67,966
+6,799
| +11% | +$208K | ﹤0.01% | 1655 |
|
|
2017
Q3 | $1.79M | Buy |
61,167
+3,203
| +6% | +$92.9K | ﹤0.01% | 1715 |
|
|
2017
Q2 | $1.72M | Buy |
57,964
+6,596
| +13% | +$181K | ﹤0.01% | 1674 |
|
|
2017
Q1 | $1.37M | Sell |
51,368
-28,336
| -36% | -$722K | ﹤0.01% | 1784 |
|
|
2016
Q4 | $2.06M | Buy |
79,704
+5,712
| +8% | +$149K | 0.01% | 1477 |
|
|
2016
Q3 | $2.03M | Buy |
73,992
+11,247
| +18% | +$297K | 0.01% | 1443 |
|
|
2016
Q2 | $1.51M | Buy |
62,745
+2,840
| +5% | +$68.4K | ﹤0.01% | 1488 |
|
|
2016
Q1 | $1.43M | Buy |
59,905
+13,555
| +29% | +$311K | ﹤0.01% | 1486 |
|
|
2015
Q4 | $1.08M | Buy |
+46,350
| New | +$1.06M | ﹤0.01% | 1593 |
|
Other funds holding ARMK
FCM
FMI
Raymond James & Associates's ARMK Position: Q3 2024 in Review
Raymond James & Associates increased its Aramark (ARMK) stake by 472% in Q3 2024, buying an estimated $2.83M and bringing the position to 97,328 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1850.
Raymond James & Associates first reported a position in ARMK in Q4 2015 and has held it in 36 quarters since. The position peaked at $13.5M in Q4 2020. 362 funds tracked by Wall St. Rank hold ARMK as of Q3 2024.
- Raymond James & Associates held 97,328 shares of Aramark worth $3.77M as of Q3 2024.
- Raymond James & Associates bought 80,300 Aramark shares in Q3 2024, an estimated $2.83M.
- Aramark made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1850 holding.
- Raymond James & Associates first reported a position in Aramark in Q4 2015 and has held it in 36 quarters since.
- Raymond James & Associates's Aramark position peaked at $13.5M in Q4 2020.
- 362 funds tracked by Wall St. Rank held Aramark as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.